Showing results (111-120 of 232) with videos related to
Sort By:
Pageof 24
The Journal of Clinical Psychiatry|March 1, 1997
Sertraline and norsertraline levels in three breastfed infantsO K Mammen, J M Perel, G Rudolph, et al.Brain Research|October 15, 1986
Behavioral effects of a single neuroleptic treatment grow with the passage of timeS M Antelman, D Kocan, D J Edwards, et al.Psychopharmacology Bulletin|January 1, 1997
Effects of the postpartum period on nortriptyline pharmacokineticsK L Wisner, J M Perel, K S Peindl, et al.The Journal of Clinical Psychiatry|May 20, 1998
Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidoneJ I Tracy, C A Monaco, G Abraham, et al.Journal of Medicinal Chemistry|March 4, 1998
Asymmetric synthesis and pharmacology of methylphenidate and its para-substituted derivativesD L Thai, M T Sapko, C T Reiter, et al.Archives of General Psychiatry|May 1, 1993
Efficacy of phenelzine and haloperidol in borderline personality disorderP H Soloff, J Cornelius, A George, et al.JAMA|April 10, 1975
Imipramine-induced heart block. A longitudinal case studyS J Kantor, J T Bigger, A H Glassman, et al.Journal of Clinical Pharmacology|February 1, 1995
Effect of alosetron (a new 5-HT3 receptor antagonist) on the pharmacokinetics of haloperidol in schizophrenic patientsS K Gupta, R L Kunka, A Metz, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1982
Pharmacokinetics of psychotropic drugs: what can it tell us?P D Hrdina, L J Hutchinson, Y D Lapierre, et al.Circulation|November 1, 1979
The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrationsE G Giardina, J T Bigger, A H Glassman, et al.Pageof 24